Important caveat: injectable and IV NAD+ are not FDA-approved (nor approved by any major regulator) for energy, metabolic or longevity uses, and their safety and efficacy for these marketed uses are not established
We prioritize speed and reliability to keep your project timelines on track.
Like, thats a fun fight, you know, and then you would probably want like Islam Makhachev versus Ilya Topuria
He didn't stop at personal use
Retatrutide is predicted at $1,200-1,500/month compared to Zepbound's $1,060
References Delta-sleep-inducing peptide (DSIP): an update PubMed DSIPa tool for investigating the sleep onset mechanism: a review PubMed DSIP in sleep disturbances PubMed DSIP/DSIP-P and circadian motor activity of rats under continuous light PubMed Sleep and sleep substances PubMed Delta sleep-inducing peptide (DSIP): a still unresolved riddle PubMed DSIPa tool for investigating the sleep onset mechanism: a review PubMed DSIP in the treatment of withdrawal syndromes from alcohol and opiates PubMed Human plasma DSIP decreases at the initiation of sleep at different circadian times PubMed The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep PubMed